Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR)

Aislan de Carvalho Vivarini1, Renata de Meirelles Santos Pereira, Karina Luiza Dias Teixeira

  • 1Laboratório de Parasitologia Molecular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, RJ, Brazil.

Insights

The type I interferon (IFN-1)/PKR pathway is crucial in Leishmania amazonensis infections. This axis, triggered by TLR2, sustains infection and influences disease severity in humans.

Area of Science:

  • Immunology
  • Molecular Biology
  • Parasitology

Background:

  • Leishmania amazonensis infection impacts immune responses.
  • The type I interferon (IFN-1) and Protein Kinase R (PKR) signaling pathway's role in leishmaniasis is not fully understood.

Purpose of the Study:

  • To investigate the type I interferon (IFN-1)/PKR axis in Leishmania amazonensis infection.
  • To elucidate the mechanisms triggering and sustaining this pathway.
  • To correlate pathway activity with disease manifestation in humans.

Main Methods:

  • Reporter assays in macrophages and HEK-293T cells.
  • Infection of Toll-like receptor 2 (TLR2)-knockout and IFN receptor (IFNR)-knockout mouse macrophages.
  • Analysis of PKR, IFN-1, and superoxide dismutase 1 (SOD1) transcript levels.
  • Immunohistochemical analysis of human leishmaniasis lesions.

Main Results:

  • Leishmania infection upregulated PKR and IFN-β expression, dependent on TLR2 engagement.
  • PKR signaling is essential for Leishmania-induced IFN-1 expression, sustaining PKR levels and enhancing infection.
  • SOD1 transcript levels increased during infection and were further enhanced by IFN-1, but abrogated by dominant-negative PKR.
  • Human lesions from anergic diffuse cutaneous leishmaniasis showed higher PKR/IFN-1 expression than localized cutaneous leishmaniasis.

Conclusions:

  • The IFN-1/PKR axis is a key player in Leishmania amazonensis infection outcome.
  • TLR2 engagement initiates the IFN-1/PKR pathway, which sustains infection and influences disease severity.
  • This pathway represents a potential target for therapeutic interventions in leishmaniasis.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...